Crossmark

IgG4-related disease: an update on pathophysiology and implications for clinical care

Published Online: 2020-09-16

Published Print: 2020-12

Authors

Perugino, Cory A.

Stone, John H.
License Information

Text and Data Mining valid from 2020-09-16

Version of Record valid from 2020-09-16
More Information

Article History

Accepted: 21 August 2020

First Online: 16 September 2020

Competing interests

: C.A.P. declares no competing interests. J.H.S. declares that he has received grants and consultation fees related to IgG4-related disease from Principia Biopharma, Roche and Viela Bio.

Document is current